Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

20.44
Delayed Data
As of 4:00pm ET
 +0.30 / +1.49%
Today’s Change
18.55
Today|||52-Week Range
263.81
-79.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues2.7B2.8B2.8B2.4B
 
 
 
 
 
Cost of Goods Sold635.5M601.0M658.8M577.6M
 
 
 
 
 
Depreciation And Amortization635.0M700.4M752.9M746.8M
 
 
 
 
 
 
Operating ExpensesGross Income1.5B1.5B1.3B1.0B
 
 
 
 
 
General Expenses766.6M799.2M815.8M915.7M
 
 
 
 
 
Other Operating Expenses176.9M5.2M42.9M5.1M
 
 
 
 
 
Research And Development81.1M101.6M95.9M103.1M
 
 
 
 
 
Total Operating Expenses2.2B2.1B2.3B2.2B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income518.4M681.0M486.8M126.4M
 
 
 
 
 
Extraordinary Charge-176.9M-233.2M-319.7M-42.2M
 
 
 
 
 
Interest Expense On Debt412.7M420.2M432.5M426.6M
 
 
 
 
 
Other Expenses5.6M-34.0M-3.3M-24.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-64.7M-5.7M-267.9M-365.7M
 
 
 
 
 
Income Taxes-13.1M-57.4M-118.5M-7.2M
 
 
 
 
 
Minority Interest-1.4M-2.2M-500.0K-800.0K
 
 
 
 
 
Net Income-53.0M49.5M-385.9M-373.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS344.4M344.9M344.9M344.9M
 
 
 
 
 
Shares To Calculate EPS Diluted344.4M351.0M344.9M344.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.15$0.14-$1.12-$1.08
 
 
 
 
 
EPS Diluted-$0.15$0.14-$1.12-$1.08